Intuitive Surgical, Inc.: insider trading
4,062 trades by 40 directors, officers and 10% owners since 2007, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$65.1 M
78 sales by 9 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$20.2 M
23 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (40)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Mark BrosiusEVP & Chief Mfg and Supply Cha | 319 | — | $5.9 M | |
| Gary LoebEVP & Chief Legal and Complian | 6,236 | — | $683 K | |
| Craig H. BarrattDirector | 0 | — | $1.0 M | |
| Gary S. GuthartDirector | 23,789 | — | $45.1 M | |
| Fredrik WidmanVP Corporate Controller | 1,026 | — | $4.9 M | |
| Patricia L. WadorsSVP Chief Human Resources Offi | 0 | — | $588 K | |
| Amy L. LaddDirector | 179 | — | $320 K | |
| David J. RosaChief Executive Officer (CEO), Director | 246,856 | — | — | |
| Iman JeddiSVP & GM da Vinci Platforms & | 6,463 | — | $2.4 M | |
| Amal M. JohnsonDirector | 13,545 | — | — | |
| Jami K. NachtsheimDirector | 6,902 | — | — | |
| Joseph C. BeeryDirector | 3,641 | — | — | |
| Keith R. LeonardDirector | 901 | — | — | |
| Lewis ChewDirector | 1,314 | — | — | |
| Monica P. ReedDirector | 2,876 | — | — | |
| Sreelakshmi KolliDirector | 1,510 | — | — | |
| Myriam CuretEVP & Chief Medical Officer | 0 | — | $4.2 M | |
| Henry L. CharltonEVP & Chief Commercial and Mkt | 11,610 | — | — | |
| Jamie SamathEVP & CFO & Enterprise Technol | 15,366 | — | — | |
| Brian Edward MillerEVP & Chief Digital Officer | 5,758 | — | — | |
| Robert DeSantisEVP & Chief Strategy & Corp Op | 5,224 | — | — | |
| Mark J. RubashDirector | 16,790 | — | — | |
| Marshall MohrExecutive VP Global Business S | 1,650 | — | — | |
| Alan J. LevyDirector | 25,888 | — | — | |
| Don R. KaniaDirector | 3,838 | — | — | |
| Michele DiMartinoSee Remarks | 2,112 | — | — | |
| Reiter Kara AndersenSr VP General Counsel & CCO | 18,067 | — | — | |
| Curet MyriamEVP & Chief Medical Officer | 94 | — | — | |
| Lonnie M. SmithDirector | 277,069 | — | — | |
| Salvatore BrognaEVP & Chief Operating Officer | 4,143 | — | — | |
| Michael A. FriedmanDirector | 4,751 | — | — | |
| Mark J. MeltzerSVP General Counsel & CCO | 10,052 | — | — | |
| George Stalk Jr.Director | 1,141 | — | — | |
| Colin MoralesGM & SVP Secondary Mkt Equip & | 124 | — | — | |
| Eric H. HalvorsonDirector | 2,485 | — | — | |
| Jerome J. McNamaraSr Advisor - Commercial Ops | 3,213 | — | — | |
| Floyd D. LoopDirector | 4,979 | — | — | |
| Augusto V. CastelloSVP Product Ops | 0 | — | — | |
| Robert W. DugganDirector | 1,000 | — | — | |
| D. Keith GrossmanDirector | 0 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -46 | $430.63 | $20 K | 319 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -46 | $437.33 | $20 K | 365 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -46 | $444.38 | $20 K | 411 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Sell10b5-1 plan | -400 | $458.15 | $183 K | 6,236 | Form 4 |
| filed | Craig H. BarrattDirector | Option exercise10b5-1 plan | +1,150 | $90.49 | $104 K | 1,150 | Form 4 |
| filed | Gary S. GuthartDirector | Sell10b5-1 plan · indirect | -10,000 | $457.34 | $4.6 M | 1.19 M | Form 4 |
| filed | Craig H. BarrattDirector | Sell10b5-1 plan | -1,150 | $460.00 | $529 K | 0 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +546 | $79.64 | $43 K | 1,572 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -63 | $453.60 | $29 K | 457 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +312 | $208.90 | $65 K | 1,884 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +325 | $139.52 | $45 K | 2,209 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +307 | $304.67 | $94 K | 2,516 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +307 | $229.39 | $70 K | 2,823 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +312 | $290.33 | $91 K | 3,135 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +406 | $347.42 | $141 K | 3,541 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +406 | $245.60 | $100 K | 3,947 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +567 | $242.34 | $137 K | 4,514 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +567 | $177.99 | $101 K | 5,081 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +262 | $166.62 | $44 K | 5,343 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +263 | $182.83 | $48 K | 5,606 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +325 | $174.26 | $57 K | 5,931 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +543 | $109.49 | $59 K | 6,474 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -5,448 | $436.06 | $2.4 M | 1,026 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -61 | $447.85 | $27 K | 520 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -61 | $441.60 | $27 K | 581 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -61 | $451.63 | $28 K | 642 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -61 | $451.75 | $28 K | 703 | Form 4 |
| filed | Craig H. BarrattDirector | Option exercise10b5-1 plan | +1,150 | $90.49 | $104 K | 1,150 | Form 4 |
| filed | Patricia L. WadorsSVP Chief Human Resources Offi | Sell10b5-1 plan | -1,078 | $443.80 | $478 K | 0 | Form 4 |
| filed | Gary S. GuthartDirector | Sell10b5-1 plan · indirect | -20,095 | $451.61 | $9.1 M | 1.20 M | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +307 | $304.67 | $94 K | 1,333 | Form 4 |
| filed | Craig H. BarrattDirector | Sell10b5-1 plan | -1,150 | $443.80 | $510 K | 0 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +307 | $229.39 | $70 K | 1,640 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +312 | $290.33 | $91 K | 1,952 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +406 | $347.42 | $141 K | 2,358 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +406 | $245.60 | $100 K | 2,764 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +567 | $242.34 | $137 K | 3,331 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +567 | $177.99 | $101 K | 3,898 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +262 | $166.62 | $44 K | 4,160 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +263 | $182.83 | $48 K | 4,423 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +325 | $174.26 | $57 K | 4,748 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +325 | $139.52 | $45 K | 5,073 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -4,047 | $453.21 | $1.8 M | 1,026 | Form 4 |
| filed | Patricia L. WadorsSVP Chief Human Resources Offi | Option exercise | +2,140 | — | — | 2,140 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Option exercise | +2,612 | — | — | 7,932 | Form 4 |
| filed | Patricia L. WadorsSVP Chief Human Resources Offi | Shares withheld for tax | -1,062 | $423.96 | $450 K | 1,078 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Shares withheld for tax | -1,296 | $423.96 | $549 K | 6,636 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +546 | $79.64 | $43 K | 1,572 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -546 | $374.44 | $204 K | 1,026 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +543 | $109.49 | $59 K | 1,569 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -543 | $374.44 | $203 K | 1,026 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -25 | $365.79 | $9 K | 764 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -23 | $347.66 | $8 K | 789 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -23 | $350.20 | $8 K | 812 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -46 | $361.23 | $17 K | 835 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -77 | $375.57 | $29 K | 881 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -77 | $396.37 | $31 K | 958 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -77 | $394.26 | $30 K | 1,035 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -77 | $394.00 | $30 K | 1,112 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -77 | $390.67 | $30 K | 1,189 | Form 4 |
| filed | Gary S. GuthartDirector | Sell10b5-1 plan · indirect | -10,000 | $400.00 | $4.0 M | 1.25 M | Form 4 |
| filed | Amy L. LaddDirector | Sell10b5-1 plan | -72 | $393.10 | $28 K | 179 | Form 4 |
| filed | Amy L. LaddDirector | Sell10b5-1 plan | -400 | $379.00 | — | 251 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Sell10b5-1 plan | -400 | $379.00 | $152 K | 5,320 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -28 | $351.00 | $10 K | 1,266 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -28 | $346.83 | $10 K | 1,294 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -28 | $360.21 | $10 K | 1,322 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -28 | $365.58 | $10 K | 1,350 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -28 | $344.00 | $10 K | 1,378 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +1,910 | — | — | 247,803 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -947 | $411.55 | $390 K | 246,856 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -25 | $414.13 | $10 K | 1,406 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -23 | $412.16 | $9 K | 1,431 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Sell10b5-1 plan | -400 | $424.14 | $170 K | 5,720 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +1,358 | — | — | 246,567 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -674 | $426.61 | $288 K | 245,893 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -23 | $424.14 | $10 K | 1,454 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -23 | $421.13 | $10 K | 1,477 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -23 | $420.12 | $10 K | 1,500 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Option exercise10b5-1 plan | +5,625 | $77.00 | $433 K | 12,088 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Sell10b5-1 plan | -5,625 | $420.55 | $2.4 M | 6,463 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -18 | $439.80 | $8 K | 1,523 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -18 | $446.04 | $8 K | 1,541 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -18 | $440.38 | $8 K | 1,559 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -18 | $440.70 | $8 K | 1,577 | Form 4 |
| filed | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -18 | $422.47 | $8 K | 1,595 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Sell10b5-1 plan | -400 | $446.95 | $179 K | 6,120 | Form 4 |
| filed | Sreelakshmi KolliDirector | Option exercise | +531 | — | — | 1,510 | Form 4 |
| filed | Joseph C. BeeryDirector | Option exercise | +531 | — | — | 3,641 | Form 4 |
| filed | Amy L. LaddDirector | Option exercise | +531 | — | — | 651 | Form 4 |
| filed | Jami K. NachtsheimDirector | Option exercise | +531 | — | — | 6,902 | Form 4 |
| filed | Lewis ChewDirector | Option exercise | +531 | — | — | 1,314 | Form 4 |
| filed | Amal M. JohnsonDirector | Option exercise | +531 | — | — | 13,545 | Form 4 |
| filed | Craig H. BarrattDirector | Option exerciseindirect | +750 | — | — | 27,948 | Form 4 |
| filed | Keith R. LeonardDirector | Option exercise | +531 | — | — | 901 | Form 4 |
| filed | Monica P. ReedDirector | Option exercise | +531 | — | — | 2,876 | Form 4 |
| filed | Amy L. LaddDirector | Sell10b5-1 plan | -119 | $463.50 | $55 K | 120 | Form 4 |
| filed | Amy L. LaddDirector | Sell10b5-1 plan | -500 | $473.46 | $237 K | 239 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +105 | $229.39 | $24 K | 105 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -105 | $493.95 | $52 K | 0 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -645 | $485.01 | $313 K | 1,613 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -648 | $490.19 | $318 K | 2,258 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -648 | $495.20 | $321 K | 2,906 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -2,362 | $498.68 | $1.2 M | 3,554 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -648 | $488.10 | $316 K | 5,916 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan · indirect | -4,728 | $487.18 | $2.3 M | 409 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -118 | $487.18 | $57 K | 1,026 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan · indirect | +125 | $208.90 | $26 K | 5,262 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan · indirect | -125 | $492.59 | $62 K | 5,137 | Form 4 |
| filed | Gary S. GuthartDirector | Option exercise | +2,506 | — | — | 11,757 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Option exercise | +626 | — | — | 2,551 | Form 4 |
| filed | Gary S. GuthartDirector | Shares withheld for tax | -1,243 | $503.51 | $626 K | 10,514 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +468 | — | — | 1,377 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Shares withheld for tax | -311 | $503.51 | $157 K | 2,240 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Shares withheld for tax10b5-1 plan | -233 | $503.51 | $117 K | 1,144 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Option exercise | +8,378 | — | — | 10,618 | Form 4 |
| filed | Gary S. GuthartDirector | Option exercise | +26,334 | — | — | 36,848 | Form 4 |
| filed | Gary S. GuthartDirector | Shares withheld for tax | -13,059 | $503.51 | $6.6 M | 23,789 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Shares withheld for tax | -4,155 | $503.51 | $2.1 M | 6,463 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +1,503 | — | — | 234,151 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise | +752 | — | — | 5,972 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Option exercise | +752 | — | — | 10,309 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option exercise | +877 | — | — | 2,776 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Option exercise | +3,148 | — | — | 8,082 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Shares withheld for tax | -373 | $503.51 | $188 K | 9,936 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan · indirect | +1,002 | — | — | 1,411 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Shares withheld for tax | -435 | $503.51 | $219 K | 2,341 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Shares withheld for tax | -335 | $503.51 | $169 K | 5,637 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -746 | $503.51 | $376 K | 233,405 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Shares withheld for tax | -1,562 | $503.51 | $786 K | 6,520 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Option exercise | +10,773 | — | — | 20,709 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Shares withheld for tax10b5-1 plan · indirect | -497 | $503.51 | $250 K | 914 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +14,363 | — | — | 247,768 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise | +10,773 | — | — | 16,410 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option exercise | +8,378 | — | — | 10,719 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Shares withheld for tax | -5,343 | $503.51 | $2.7 M | 15,366 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Shares withheld for tax | -4,800 | $503.51 | $2.4 M | 11,610 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Shares withheld for tax | -4,155 | $503.51 | $2.1 M | 6,564 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan · indirect | +8,378 | — | — | 9,292 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -7,122 | $503.51 | $3.6 M | 240,646 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +9,052 | — | — | 249,698 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Shares withheld for tax10b5-1 plan · indirect | -4,155 | $503.51 | $2.1 M | 5,137 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -4,489 | $503.51 | $2.3 M | 245,209 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -249 | $499.71 | $124 K | 909 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan · indirect | -2,345 | $499.71 | $1.2 M | 409 | Form 4 |
| filed | Patricia L. WadorsSVP Chief Human Resources Offi | Sell10b5-1 plan | -220 | $499.71 | $110 K | 0 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Option exercise | +1,526 | — | — | 5,230 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option exercise | +1,622 | — | — | 2,214 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise | +1,717 | — | — | 5,414 | Form 4 |
| filed | Patricia L. WadorsSVP Chief Human Resources Offi | Option exercise10b5-1 plan | +458 | — | — | 458 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Option exercise | +1,622 | — | — | 2,207 | Form 4 |
| filed | Gary S. GuthartDirector | Option exercise | +4,960 | — | — | 9,981 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +3,816 | — | — | 233,386 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exerciseindirect | +3,052 | — | — | 3,461 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Option exercise | +1,908 | — | — | 9,707 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise | +611 | — | — | 1,271 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -1,892 | $506.17 | $958 K | 231,494 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Shares withheld for taxindirect | -1,514 | $506.17 | $766 K | 1,947 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Shares withheld for tax | -765 | $506.17 | $387 K | 4,649 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Shares withheld for tax | -303 | $506.17 | $153 K | 968 | Form 4 |
| filed | Patricia L. WadorsSVP Chief Human Resources Offi | Shares withheld for tax10b5-1 plan | -238 | $506.17 | $120 K | 220 | Form 4 |
| filed | Gary S. GuthartDirector | Shares withheld for tax | -2,460 | $506.17 | $1.2 M | 7,521 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Shares withheld for tax | -900 | $506.17 | $456 K | 8,807 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Shares withheld for tax | -805 | $506.17 | $407 K | 1,409 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Shares withheld for tax | -757 | $506.17 | $383 K | 4,473 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Shares withheld for tax | -631 | $506.17 | $319 K | 1,576 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Option exercise | +687 | — | — | 2,263 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Option exercise | +916 | — | — | 5,389 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +2,289 | — | — | 233,783 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Option exercise | +1,488 | — | — | 10,295 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option exercise | +973 | — | — | 2,382 | Form 4 |
| filed | Gary S. GuthartDirector | Option exercise | +3,433 | — | — | 10,954 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exerciseindirect | +1,602 | — | — | 3,549 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise | +378 | — | — | 1,346 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise | +1,030 | — | — | 5,679 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Shares withheld for tax | -188 | $506.17 | $95 K | 1,158 | Form 4 |
| filed | Gary S. GuthartDirector | Shares withheld for tax | -1,703 | $506.17 | $862 K | 9,251 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Shares withheld for tax | -483 | $506.17 | $244 K | 1,899 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Shares withheld for tax | -738 | $506.17 | $374 K | 9,557 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Shares withheld for tax | -341 | $506.17 | $173 K | 1,922 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -1,135 | $506.17 | $575 K | 232,648 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Shares withheld for tax | -455 | $506.17 | $230 K | 4,934 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Shares withheld for taxindirect | -795 | $506.17 | $402 K | 2,754 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Shares withheld for tax | -459 | $506.17 | $232 K | 5,220 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -133 | $494.96 | $66 K | 660 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan · indirect | -421 | $494.96 | $208 K | 409 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan · indirect | +838 | — | — | 1,247 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +567 | — | — | 1,095 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Shares withheld for tax10b5-1 plan · indirect | -417 | $492.84 | $206 K | 830 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Shares withheld for tax10b5-1 plan | -302 | $492.84 | $149 K | 793 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan · indirect | +105 | $229.39 | $24 K | 935 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan · indirect | -105 | $494.65 | $52 K | 830 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option exercise | +838 | — | — | 1,025 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise | +1,077 | — | — | 4,189 | Form 4 |
| filed | Gary S. GuthartDirector | Option exercise | +2,633 | — | — | 6,327 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise | +1,436 | — | — | 230,294 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Option exercise | +838 | — | — | 894 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Option exercise | +315 | — | — | 3,876 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Option exercise | +1,077 | — | — | 8,295 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Shares withheld for tax | -492 | $492.84 | $242 K | 3,697 | Form 4 |
| filed | Iman JeddiSVP & GM da Vinci Platforms & | Shares withheld for tax | -309 | $492.84 | $152 K | 585 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Shares withheld for tax | -433 | $492.84 | $213 K | 592 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Shares withheld for tax | -724 | $492.84 | $357 K | 229,570 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Shares withheld for tax | -172 | $492.84 | $85 K | 3,704 | Form 4 |
| filed | Gary S. GuthartDirector | Shares withheld for tax | -1,306 | $492.84 | $644 K | 5,021 | Form 4 |
| filed | Jamie SamathEVP & CFO & Enterprise Technol | Shares withheld for tax | -496 | $492.84 | $244 K | 7,799 | Form 4 |
| filed | Keith R. LeonardDirector | Other | -369 | — | — | 370 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +126 | $208.90 | $26 K | 126 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -126 | $520.02 | $66 K | 0 | Form 4 |
| filed | Gary S. GuthartDirector | Option exercise10b5-1 plan | +25,500 | $174.26 | $4.4 M | 28,194 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +105 | $229.39 | $24 K | 105 | Form 4 |
| filed | Gary S. GuthartDirector | Sell10b5-1 plan | -24,500 | $530.10 | $13.0 M | 3,694 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -105 | $532.61 | $56 K | 0 | Form 4 |
| filed | Gary S. GuthartDirector | Sell10b5-1 plan · indirect | -1,400 | $531.53 | $744 K | 15,720 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +125 | $208.90 | $26 K | 125 | Form 4 |
| filed | Gary S. GuthartDirector | Sell10b5-1 plan · indirect | -1,400 | $531.52 | $744 K | 15,720 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -125 | $532.61 | $67 K | 0 | Form 4 |
| filed | Mark BrosiusSee Remarks | Sell10b5-1 plan | -464 | $548.49 | $254 K | 131 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -464 | $548.49 | $254 K | 443 | Form 4 |
| filed | Mark BrosiusSee Remarks | Sell10b5-1 plan · amended | -312 | $547.36 | $171 K | 595 | Form 4/A |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option exercise10b5-1 plan | +4,500 | $79.64 | $358 K | 5,407 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -4,500 | $547.36 | $2.5 M | 907 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +104 | $229.39 | $24 K | 104 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -104 | $559.90 | $58 K | 0 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Option exercise10b5-1 plan | +25,500 | $139.52 | $3.6 M | 25,500 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +125 | $208.90 | $26 K | 125 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan | -22,806 | $570.89 | $13.0 M | 2,694 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -125 | $568.99 | $71 K | 0 | Form 4 |
| filed | Craig H. BarrattDirector | Option exercise10b5-1 plan | +750 | $71.32 | $53 K | 750 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise10b5-1 plan | +636 | $347.42 | $221 K | 8,423 | Form 4 |
| filed | Keith R. LeonardDirector | Gift | -1,606 | — | — | 739 | Form 4 |
| filed | Craig H. BarrattDirector | Sell10b5-1 plan | -750 | $580.00 | $435 K | 0 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Sell10b5-1 plan | -636 | $580.00 | $369 K | 7,787 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise10b5-1 plan | +2,565 | $245.60 | $630 K | 10,352 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Sell10b5-1 plan | -2,565 | $580.00 | $1.5 M | 7,787 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise10b5-1 plan | +2,898 | $242.34 | $702 K | 10,685 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Sell10b5-1 plan | -2,898 | $580.00 | $1.7 M | 7,787 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Option exercise10b5-1 plan | +2,901 | $177.99 | $516 K | 10,688 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Sell10b5-1 plan | -2,901 | $580.00 | $1.7 M | 7,787 | Form 4 |
| filed | Henry L. CharltonEVP & Chief Commercial and Mkt | Sell10b5-1 plan | -4,731 | $580.00 | $2.7 M | 3,056 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +105 | $229.39 | $24 K | 105 | Form 4 |
| filed | Brian Edward MillerEVP & Chief Digital Officer | Option exercise10b5-1 plan | +1,298 | $229.39 | $298 K | 7,056 | Form 4 |
| filed | Brian Edward MillerEVP & Chief Digital Officer | Sell10b5-1 plan | -1,298 | $575.00 | $746 K | 5,758 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -105 | $560.00 | $59 K | 0 | Form 4 |
| filed | Brian Edward MillerEVP & Chief Digital Officer | Option exercise10b5-1 plan | +2,202 | $208.90 | $460 K | 7,960 | Form 4 |
| filed | Brian Edward MillerEVP & Chief Digital Officer | Sell10b5-1 plan | -2,202 | $575.00 | $1.3 M | 5,758 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +1,908 | $77.00 | $147 K | 2,381 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -1,908 | $550.00 | $1.0 M | 473 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Option exercise10b5-1 plan | +159 | $59.46 | $9 K | 632 | Form 4 |
| filed | Fredrik WidmanVP Corporate Controller | Sell10b5-1 plan | -159 | $550.00 | $87 K | 473 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Gift | -5,454 | — | — | 228,802 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +125 | $208.90 | $26 K | 125 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -125 | $543.00 | $68 K | 0 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +5,030 | $242.34 | $1.2 M | 5,383 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -5,030 | $548.43 | $2.8 M | 353 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +1,153 | $229.39 | $264 K | 1,506 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -1,153 | $548.43 | $632 K | 353 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +1,379 | $208.90 | $288 K | 1,732 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -1,379 | $548.43 | $756 K | 353 | Form 4 |
| filed | Craig H. BarrattDirector | Option exercise10b5-1 plan | +2,193 | $71.32 | $156 K | 2,193 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Option exercise10b5-1 plan | +36,000 | $109.49 | $3.9 M | 55,827 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Option exercise10b5-1 plan | +27,000 | $79.64 | $2.2 M | 258,756 | Form 4 |
| filed | David J. RosaChief Executive Officer (CEO), Director | Sell10b5-1 plan | -24,500 | $547.55 | $13.4 M | 234,256 | Form 4 |
| filed | Craig H. BarrattDirector | Sell10b5-1 plan | -2,193 | $548.01 | $1.2 M | 0 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan | -28,800 | $547.56 | $15.8 M | 27,027 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan · indirect | -1,400 | $546.35 | $765 K | 17,120 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan · indirect | -1,400 | $546.18 | $765 K | 17,120 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Option exercise | +2,612 | — | — | 4,857 | Form 4 |
| filed | Gary LoebEVP & Chief Legal and Complian | Shares withheld for tax | -1,296 | $443.76 | $575 K | 3,561 | Form 4 |
| filed | Amy L. LaddDirector | Sell10b5-1 plan | -335 | $440.69 | $148 K | 739 | Form 4 |
| filed | Amy L. LaddDirector | Sell10b5-1 plan | -336 | $470.11 | $158 K | 1,074 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Option exercise10b5-1 plan | +36,000 | $79.64 | $2.9 M | 49,187 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan | -29,360 | $472.49 | $13.9 M | 19,827 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Option exercise10b5-1 plan | +7,893 | $59.46 | $469 K | 21,080 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan | -7,893 | $498.64 | $3.9 M | 13,187 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan · indirect | -1,400 | $495.23 | $693 K | 18,520 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Sell10b5-1 plan · indirect | -1,400 | $495.24 | $693 K | 18,520 | Form 4 |
| filed | Gary S. GuthartExecutive Chair of the Board o, Director | Gift10b5-1 plan · indirect | -10,500 | — | — | 1.20 M | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Option exercise10b5-1 plan | +4,500 | $242.34 | $1.1 M | 4,853 | Form 4 |
| filed | Myriam CuretEVP & Chief Medical Officer | Sell10b5-1 plan | -4,500 | $492.48 | $2.2 M | 353 | Form 4 |
| filed | David J. RosaPresident, Director | Option exercise | +1,358 | — | — | 232,430 | Form 4 |
| filed | David J. RosaPresident, Director | Shares withheld for tax | -674 | $526.15 | $355 K | 231,756 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -216 | $563.11 | $122 K | 907 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -215 | $560.70 | $121 K | 1,123 | Form 4 |
| filed | David J. RosaPresident, Director | Gift | -851 | — | — | 231,072 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -215 | $552.07 | $119 K | 1,338 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -215 | $550.68 | $118 K | 1,553 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -215 | $549.06 | $118 K | 1,768 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -20 | $563.81 | $11 K | 1,983 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -22 | $560.00 | $12 K | 2,003 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -22 | $563.00 | $12 K | 2,025 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -22 | $561.67 | $12 K | 2,047 | Form 4 |
| filed | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sell10b5-1 plan | -22 | $551.97 | $12 K | 2,069 | Form 4 |
| filed | Jamie SamathSee Remarks | Option exercise10b5-1 plan | +188 | $208.90 | $39 K | 7,350 | Form 4 |
| filed | Jamie SamathSee Remarks | Option exercise10b5-1 plan | +269 | $229.39 | $62 K | 7,619 | Form 4 |
| filed | Jamie SamathSee Remarks | Option exercise10b5-1 plan | +188 | $290.33 | $55 K | 7,807 | Form 4 |
| filed | Jamie SamathSee Remarks | Option exercise10b5-1 plan | +270 | $304.67 | $82 K | 8,077 | Form 4 |
| filed | Jamie SamathSee Remarks | Sell10b5-1 plan | -915 | $527.95 | $483 K | 7,162 | Form 4 |
| filed | Jami K. NachtsheimDirector | Option exercise10b5-1 plan | +2,400 | $90.49 | $217 K | 8,771 | Form 4 |
| filed | Jami K. NachtsheimDirector | Sell10b5-1 plan | -2,400 | $520.00 | $1.2 M | 6,371 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice